About: Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2002 (uk) im Juni 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 2002 (ast) scientific article published on 01 June 2002 (en)
publication date	wds:Q74422856-E0B571C4-486C-42AD-98A7-446109458FBD
publication date	2002-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74422856-0D50B8EB-5A93-4DE2-A13C-C8E7F8E84704
language of work or name	English
cites work	wds:Q74422856-1A00708D-E824-4DC7-8181-D66119ACF697 wds:Q74422856-3A75B079-4494-4E99-BE8B-87CED4C5558A wds:Q74422856-4D578A9B-F6FA-4FA1-86BB-BD7A9D6A18C8 wds:Q74422856-5EAE33E6-4590-482C-B516-E4AF5CC8E47C wds:Q74422856-601B022E-C5FF-472E-B3F5-348D673A772F wds:Q74422856-6F466DEE-81B8-431F-93E7-FECFD74DB235 wds:Q74422856-82007212-885B-4A61-BFD0-B26C6B393F30 wds:Q74422856-86FE0099-1FFA-436F-9566-0C0866157C3E wds:Q74422856-8BF3060B-6288-431B-ADE7-3EF11F09094C wds:Q74422856-9C532A9E-BF64-4BE3-BE37-9E5D3E948F47 wds:Q74422856-B66DEE5D-69E0-4F2A-AEB9-C3664923131F
cites work	Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers A benefit-cost analysis of two-dose measles immunization in Canada Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state Cost-utility analyses of clinical preventive services: published ratios, 1976-1997. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Are proxy assessments of health status after stroke with the EuroQol questionnaire feasible, accurate, and unbiased? Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California
author name string	wds:Q74422856-0F834A5C-8E8B-46AC-B795-97C797EAD8E3 wds:Q74422856-30B3A965-EF8D-4C35-BEC2-4E940AFDAB15
author name string	Philippe De Wals Lonny Erickson
rdfs:label	Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (en) Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (nl)
skos:prefLabel	Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (en) Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (nl)
name	Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (en) Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (nl)
title	wds:Q74422856-5D9B88F4-3C7B-420C-800E-C951DBC4A8A3
title	Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec (en)
page(s)	wds:Q74422856-BEED0E78-D78C-4E75-9478-E5E6B3FF2B50
page(s)	2840-2844
instance of	wds:Q74422856-588385AD-2C72-4BF3-92B5-FFCDE4D53CA2
instance of	scholarly article
main subject	wds:Q74422856-063A2D32-E212-4DE8-A5D2-5C1A782C0B57 wds:Q74422856-105A5F6A-141F-4FD4-AA17-3948EE08DCCA
main subject	mass vaccination meningococcal disease
PubMed ID	wds:Q74422856-C7CE342E-E24A-4FF1-8FCC-00FBFEB0A3DF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12102036
PubMed ID	12102036
published in	wds:Q74422856-438535EB-36DF-4E90-89A9-55DE42623A53
published in	Vaccine
issue	wds:Q74422856-8B007EE8-A9ED-4A92-8514-44F788D99D1A
volume	wds:Q74422856-08DFD78F-D132-4786-AF11-EE5F6FF6044F
issue	21-22
volume	20
DOI	wds:Q74422856-7BF587DE-FDF8-4B08-A313-1A2C2B7F8FEB
DOI	http://dx.doi.org/10.1016/S0264-410X(02)00161-5
DOI	10.1016/S0264-410X(02)00161-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74422856
is cites work of	Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease The impact of new vaccine introduction on immunization and health systems: a review of the published literature Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis Methodological concerns with economic evaluations of meningococcal vaccines The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story Economic evaluation of vaccines in Canada: A systematic review Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country. Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis The societal value of universal childhood vaccination. Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada Should university students be vaccinated against meningococcal disease in Canada? Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Economic evaluations of vaccines in Canada: a scoping review
is cites work of	wds:Q36253528-59C47B12-E336-4F3B-939C-EB23032A8478 wds:Q92309241-4E15A3B4-D254-412B-BAA2-BC1B3BD5C962 wds:Q36294177-190B5DF0-3975-4D23-BED6-0D3E505D8A7A wds:Q37131005-F2C1D56B-8197-421B-9F4A-35CAA8D0ADAC wds:Q91578398-A1650426-61E1-4C27-95ED-783DBC5E5BF7 wds:Q35073151-4800C777-5C5B-4168-AF8E-5030F3317151 wds:Q36170714-7C37C2E1-9422-4C5D-B175-FCD07358DD65 wds:Q27009450-5DC8338C-F7E0-4CD2-971D-D16531635E6E wds:Q35887617-B009767F-94B3-431B-9831-9D6A245B7A6E wds:Q79740329-BDB7503A-B7CF-44B7-B45F-1753F600B5F3 wds:Q47583090-088AB0E5-63C2-479E-8D55-FCAB12B8D553 wds:Q35901353-B94A5B68-D9D2-4E91-A8BB-141472A9F366 wds:Q80460188-E6FA89F7-7535-4F1A-A39E-EB5D109109C2 wds:Q33644881-6200B024-10CE-4DB3-83E2-ADA8DE66DC91 wds:Q35762047-9ED9C01E-741F-4EBD-8B03-25496866FED9 wds:Q37750738-1E851FFE-8FA6-4014-A18B-BB9887C7528A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software